Two Sigma Investments, LP Idera Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.53 - $1.03 $140,900 - $273,825	-265,850 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.0 - $1.18 $177,900 - $209,922	177,900 Added 202.27%	265,850 $274,000
Q2 2021 Aug 16, 2021	SELL	$1.01 - $1.58 $227,554 - $355,975	-225,301 Reduced 71.92%	87,950 $106,000
Q1 2021 May 17, 2021	BUY	$1.23 - $5.98 $253,782 - $1.23 Million	206,327 Added 192.97%	313,251 $407,000
Q4 2020 Feb 16, 2021	BUY	$2.09 - $5.18 $223,471 - $553,866	106,924 New	106,924 $392,000
Q4 2019 Feb 14, 2020	SELL	$1.45 - $2.79 $23,358 - $44,944	-16,109 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.12 - $3.31 $34,151 - $53,320	16,109 New	16,109 $47,000
Q2 2019 Aug 14, 2019	SELL	$2.37 - $3.97 $396,543 - $664,252	-167,318 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.33 - $3.79 $99,518 - $161,878	42,712 Added 34.28%	167,318 $427,000
Q4 2018 Feb 14, 2019	BUY	$2.77 - $9.38 $304,949 - $1.03 Million	110,090 Added 758.4%	124,606 $345,000
Q3 2018 Nov 14, 2018	BUY	$5.53 - $11.36 $80,273 - $164,901	14,516 New	14,516 $129,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.